Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Antiviral activity of amiodarone in SARS-CoV-2 disease

R. Bílek, V. Danzig, T. Grimmichová

. 2022 ; 71 (6) : 869-875. [pub] 20221125

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22029565

Amiodarone seems to exhibit some antiviral activity in the disease caused by SARS-CoV-2. Here we have examined the SARS-CoV-2 disease course in the entire population of the Czech Republic and compared it with the course of the disease in patients treated with amiodarone in two major Prague's hospitals. In the whole population of the Czech Republic SARS-CoV-2 infected 1665070 persons (15.6 %) out of 10694000 (100 %) between 1 April 2020 and 30 June 2021. In the same time period only 35 patients (3.4 %) treated with amiodarone were infected with SARS-CoV-2 virus out of 1032 patients (100 %) who received amiodarone. It appears that amiodarone can prevent SARS-CoV-2 virus infection by multiple mechanisms. In in-vitro experiments it exhibits SARS-CoV-2 virus replication inhibitions. Due to its anti-inflammatory and antioxidant properties, it may have beneficial effect on the complications caused by SARS-CoV-2 as well. Additionally, inorganic iodine released from amiodarone can be converted to hypoiodite (IO-), which has antiviral and antibacterial activity, and thus can affect the life cycle of the virus.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22029565
003      
CZ-PrNML
005      
20230522114147.0
007      
ta
008      
230113s2022 xr da f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934974 $2 doi
035    __
$a (PubMed)36426888
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Bílek, Radovan, $d 1954- $7 jo20000074070 $u Institute of Endocrinology, Prague, Czech Republic
245    10
$a Antiviral activity of amiodarone in SARS-CoV-2 disease / $c R. Bílek, V. Danzig, T. Grimmichová
520    9_
$a Amiodarone seems to exhibit some antiviral activity in the disease caused by SARS-CoV-2. Here we have examined the SARS-CoV-2 disease course in the entire population of the Czech Republic and compared it with the course of the disease in patients treated with amiodarone in two major Prague's hospitals. In the whole population of the Czech Republic SARS-CoV-2 infected 1665070 persons (15.6 %) out of 10694000 (100 %) between 1 April 2020 and 30 June 2021. In the same time period only 35 patients (3.4 %) treated with amiodarone were infected with SARS-CoV-2 virus out of 1032 patients (100 %) who received amiodarone. It appears that amiodarone can prevent SARS-CoV-2 virus infection by multiple mechanisms. In in-vitro experiments it exhibits SARS-CoV-2 virus replication inhibitions. Due to its anti-inflammatory and antioxidant properties, it may have beneficial effect on the complications caused by SARS-CoV-2 as well. Additionally, inorganic iodine released from amiodarone can be converted to hypoiodite (IO-), which has antiviral and antibacterial activity, and thus can affect the life cycle of the virus.
650    _2
$a lidé $7 D006801
650    12
$a COVID-19 $7 D000086382
650    _2
$a antivirové látky $x farmakologie $x terapeutické užití $7 D000998
650    _2
$a SARS-CoV-2 $7 D000086402
650    12
$a amiodaron $x farmakologie $x terapeutické užití $7 D000638
650    _2
$a antibakteriální látky $7 D000900
655    _2
$a časopisecké články $7 D016428
700    1_
$a Danzig, Vilém, $d 1964- $7 ola2006345267 $u 2nd Department of Medicine, Cardiology and Angiology, Charles University, General University Hospital, Prague, Czech Republic
700    1_
$a Grimmichová, Tereza $7 xx0229684 $u Institute of Endocrinology, Prague, Czech Republic $u The University Hospital Kralovske Vinohrady, Dept. of Internal Medicine, Division of Diabetology and Endocrinology, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 6 (2022), s. 869-875
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36426888 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20230113 $b ABA008
991    __
$a 20230522114145 $b ABA008
999    __
$a ok $b bmc $g 1894760 $s 1180890
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 71 $c 6 $d 869-875 $e 20221125 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20230113

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace